Dexcom Inc. is a global leader in continuous glucose monitoring (CGM) technology, empowering people with diabetes to manage their health through innovative, real-time glucose sensing systems.
Import Shipments
Distribution Centers
Annual Revenue
Founded
Dexcom has recently focused on expanding its G7 CGM system globally, enhancing device interoperability, and advancing digital health integration to improve diabetes management outcomes.
Global rollout and regulatory approvals for the Dexcom G7 system
Strategic efforts to expand market presence and reach new customer segments.
Implementation of advanced technologies to improve service delivery and customer experience.
Dexcom Inc. designs and produces real-time CGM systems that allow users to continuously monitor their glucose levels with a small sensor worn under the skin. Its flagship products, including the Dexcom G6 and G7, transmit glucose data wirelessly to smartphones or receivers, eliminating the need for routine fingersticks and enabling better diabetes management. Dexcom’s technology is widely adopted by patients, caregivers, and healthcare professionals, and is integrated with other diabetes management devices such as insulin pumps. The company’s ongoing innovation and global reach have established it as a leader in diabetes technology, serving millions of users in over 50 countries.
San Diego, California, USA
1999
DXCM
